Exact Sciences Explains: BLUE-C
![](/-/media/project/exactcore/images/educational-resources/placeholder-1/exact-explains-blue-c.png?rev=419e0dd26d784b47b15dc002739386af&w=750&hash=35C8389946C7576B8EACC15BDF810CAC)
The BLUE-C clinical trial is one of the largest colorectal cancer screening trials ever conducted. Designed to evaluate the performance of the next-generation Cologuard® test, the study produced results demonstrating a new performance standard in non-invasive colorectal cancer detection.
Learn more:
The next-generation Cologuard test is not cleared or approved by the US Food and Drug Administration (FDA) or any other national regulatory authority.